The major changes in the company, Zhao Deqing, the former chairman of the company, are of course clear.

I contacted the broker again as soon as possible, hoping to talk to Wu Zhou again, at least add a little more.

"Mr. Wu said, the market value is as much as it is, to be calculated according to the market price, in fact, Mr. Zhao, my suggestion is that you can keep the stocks, after all, Mr. Wu also said, at least ten years in the future, all profits will be invested in the company's research and development, you think, there is such a heavy research and development of Mr. Wu, the future of your stocks will definitely make a lot of money, ten years later, at least double."

Zhao Deqing rolled his eyes directly when he heard this, isn't it because of Wu Zhou's decision that he is in such a hurry to sell now.

In the medical industry, although it focuses on research and development, there may be breakthroughs.

But it doesn't mean that there will be a breakthrough if you focus on research and development.

And even if all the profits of the entire company are added to the more than 100 million yuan a year, and the head of a single domestic enterprise for medical devices, with billions of R&D expenses for so many years, why can Wu Zhou, such a layman, manage the company, and give full play to the effect of dozens of times the capital.

In his opinion, Wu Zhou's R&D strategy is good, even if he is an outsider, he has to say that he is really courageous, but that's all, he doesn't have much hope for the company's future.

In addition, as a former chairman whose position was wiped out, with so many shares, there is neither a post salary nor a dividend, and there is no dividend for ten years.

Such a big asset, if you cash out directly, it's not good to use it anywhere.

And these shares are most of his net worth, and some time ago, pulling out a group of people from the original company and starting a new stove also cost money.

So after all consideration, he decided to sell it immediately.

"Mr. Liu, Ming people don't say secret words, you can help me talk to Mr. Wu about this matter, after the matter is completed, the extra part, two and one will be added to five." Zhao Deqing finally gritted his teeth and said.

After the broker heard Zhao Deqing's words, his breath was stagnant.

Zhao Deqing could hear the other side on the phone, and then took a deep breath.

"Mr. Zhao, this is busy, I really want to help, but I really can't help, you can sum it up yourself, it's at this price, Mr. Wu seems to be going back tomorrow, he is very busy, and next time it may not be when." Just kidding, if it were the first time to cooperate with Wu Zhou, there was a high probability that the broker would really agree to Zhao Deqing's plan.

After all, who can refuse such a large sum of money.

But the experience of working with Wu Zhou many times told him that Wu Zhou has a very powerful intelligence network.

I think that at the beginning, the first medical device company, before he started talking, Wu Zhou directly gave him a list, the psychological bottom line price of each shareholder.

At first, he thought that those bottom line prices were just a joke, but in the subsequent negotiation process, he found out.

Almost without exception, in the end, they are all traded at the bottom price.

And the bottom line price of Zhao Deqing given by Mr. Wu is the original price.

Therefore, as a role just a microphone, he has no room to make the difference.

"Okay, that's the price."

After a long silence, Zhao Deqing finally compromised without surprise.

After all, Wu Zhou has already obtained the vast majority of the company's shares, and as a top billionaire worth hundreds of billions, there are means, or a team that can help him hollow out the acquired company.

If he really wants to go against Wu Zhou, there is a high probability that his result in the end will be nothing.

It's better to settle in the pocket, with such a large amount of money, it is enough.

"Mr. Zhao, I have to confirm with you again, you won't change your hexagram when you get to the scene."

Among the three medical device companies, Zhao Deqing and Mi Xuexia's medical device company acquired the most troublesome, but the acquisition amount was also the lowest, and in the end, it only cost 3.5 billion.

Originally, it was a 50% premium, but in the end, because of the couple's various tosses, the overall actual premium was only 25%.

This one after the other saved Wu Zhou 700 million.

The three medical device companies in hand spent Wu Zhou a total of 15.3 billion.

Coupled with the 7 billion on Sinovac's side, and the signing fee of some talents, the top researchers who have arrived in March have received project funds.

Biomedicine, before and after, has also spent nearly 10 billion.

This adds up, and the number is quite incentive, almost 25 billion.

In January and February, in this special market situation, Wu Zhou's company's total sales revenue profit was about 28.3 billion.

With additional income, about 2,000 mask production lines have been booked, with a payment of 3.6 billion and an estimated profit of about 3 billion.

So add it up.

In the first two months, Wu Zhou's total profit was about 31.3 billion.

This time spent 25 billion, but if you look at the company's financial report, there is still a profit of 6.3 billion on the account.

is also because this money is enough, and Wu Zhou is also lavish enough to spend it.

On the medical device company's side, all the revenue and profits in the next ten years were spent on the company's industrial chain research and development.

This is no joke, of course it is to do the best.

Throughout early March, Wu Zhou devoted almost all of his time to these medical-related enterprises in his hands.

After all, so much money was spent.

The medical device companies that were bought were all the result of Wu Zhou's careful selection.

It's not just the potential of our own R&D team.

There is also the production capacity and technical capacity of the OEM factory controlled by the company.

There are the best OEM factories in the domestic industry, and the production quality is top even in the world.

In addition, there are few domestic manufacturers with core technology and leading technology, and some of the core component technologies of medical devices can be directly produced, although the performance is slightly inferior to the national first-line level, but it is not much.

Since we have the best OEM quality control factory in hand, of course, the related products of the three medical devices can be transferred over as soon as possible.

However, there are some things that factories may not be able to produce.

At this time, it is the targeted design and debugging of some engineers, and the production level of other holdings is average, the rectification of the rectification, the suspension of production, and the production of the production must be improved.

The optimization of industrial chain production will also be combined with the original technical department of Wuzhou Company to coordinate and cooperate, and strive for further improvement in quality control and automated production.

As for the core component technology, since it is not as good as the international first-line, then increase research and development, and strive to reach the international first-line, or even exceed their level, at the same time, Wu Zhou will also screen the necessary patents to see if they can buy it.

Let's find out if the top bulls behind these technologies can be poached.

Scientific research requires time, money, people, and direction. After all, the direction is wrong, and everything is in vain.

It just so happens that these things, except for the time can't be helped, Wu Zhou can be satisfied.

After many days of continuous rotation, Wu Zhou also felt a little tired in his brain.

But suddenly Wu Zhou saw a piece of news.

"On March 9, the New Zealand stock market opened with a sharp decline, triggering the circuit breaker mechanism, and the composite index fell by more than 7%."

Wu Zhou."

(End of chapter)